309 related articles for article (PubMed ID: 9299599)
1. Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters.
Eckhoff C; Willhite CC
Toxicol Appl Pharmacol; 1997 Sep; 146(1):79-87. PubMed ID: 9299599
[TBL] [Abstract][Full Text] [Related]
2. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
[TBL] [Abstract][Full Text] [Related]
3. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
Hummler H; Hendrickx AG; Nau H
Teratology; 1994 Sep; 50(3):184-93. PubMed ID: 7871482
[TBL] [Abstract][Full Text] [Related]
4. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
Willhite CC; Lovey A; Eckhoff C
Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
[TBL] [Abstract][Full Text] [Related]
5. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
6. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
[TBL] [Abstract][Full Text] [Related]
7. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.
Kraft JC; Slikker W; Bailey JR; Roberts LG; Fischer B; Wittfoht W; Nau H
Drug Metab Dispos; 1991; 19(2):317-24. PubMed ID: 1676630
[TBL] [Abstract][Full Text] [Related]
8. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
9. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
10. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
Kochhar DM; Jiang H; Penner JD; Heyman RA
Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
[TBL] [Abstract][Full Text] [Related]
11. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
12. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
Tembe EA; Honeywell R; Buss NE; Renwick AG
Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
[TBL] [Abstract][Full Text] [Related]
14. Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors.
Wang DL; Marko M; Dahl AR; Engelke KS; Placke ME; Imondi AR; Mulshine JL; De Luca LM
Clin Cancer Res; 2000 Sep; 6(9):3636-45. PubMed ID: 10999756
[TBL] [Abstract][Full Text] [Related]
15. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
Tzimas G; Thiel R; Chahoud I; Nau H
Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoyl-beta-glucuronide is a potent teratogen in the mouse because of extensive metabolism to all-trans-retinoic acid.
Nau H; Elmazar MM; Rühl R; Thiel R; Sass JO
Teratology; 1996 Sep; 54(3):150-6. PubMed ID: 8987158
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
18. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
Satre MA; Penner JD; Kochhar DM
Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
[TBL] [Abstract][Full Text] [Related]
20. Developmental stage-associated differences in the transplacental distribution of 13-cis- and all-trans-retinoic acid as well as their glucuronides in rats and mice.
Tzimas G; Collins MD; Nau H
Toxicol Appl Pharmacol; 1995 Jul; 133(1):91-101. PubMed ID: 7597714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]